Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 22

    1.

    Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer: A North Central Cancer Treatment Group Study.

    Bryce AH, Mattar B, Hillman SL, Adjei AA, Kugler JW, Rowland K Jr, Wender DB, Soori G, Perez EA, Jett JR.

    Am J Clin Oncol. 2009 Nov 22. [Epub ahead of print]PMID: 19935387 [PubMed - as supplied by publisher]

    2.

    Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer.

    Mandrekar SJ, Qi Y, Hillman SL, Ziegler KL, Reuter NF, Rowland KM Jr, Kuross SA, Marks RS, Schild SE, Adjei AA.

    J Thorac Oncol. 2009 Oct 30. [Epub ahead of print]PMID: 19884856 [PubMed - as supplied by publisher]Related articles

    3.

    Reply to P. Prassopoulos et al.

    Hillman SL, Sargent DJ.

    J Clin Oncol. 2009 Oct 19. [Epub ahead of print] No abstract available. PMID: 19841317 [PubMed - as supplied by publisher]Related articles

    4.

    Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation.

    Hillman SL, An MW, O'Connell MJ, Goldberg RM, Schaefer P, Buckner JC, Sargent DJ.

    J Clin Oncol. 2009 Jul 1;27(19):3205-10. Epub 2009 May 4.PMID: 19414682 [PubMed - indexed for MEDLINE]Related articles

    5.

    Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

    Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

    Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.PMID: 18838724 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

    Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, Wos EJ, Moore DF, Kugler JW, Windschitl HE, Graham DL, Bernath AM Jr, Fitch TR, Soori GS, Jett JR, Adjei AA, Perez EA.

    Lung Cancer. 2008 May;60(2):200-7. Epub 2007 Nov 28.PMID: 18045731 [PubMed - indexed for MEDLINE]Related articles

    7.

    A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.

    Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR.

    Cancer. 2006 Aug 15;107(4):781-92.PMID: 16847887 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.

    Ma CX, Nair S, Thomas S, Mandrekar SJ, Nikcevich DA, Rowland KM, Fitch TR, Windschitl HE, Hillman SL, Schild SE, Jett JR, Obasaju C, Adjei AA; North Central Cancer Treatment Group; Mayo Clinic; Eli Lilly & Company.

    J Clin Oncol. 2005 Sep 1;23(25):5929-37.PMID: 16135464 [PubMed - indexed for MEDLINE]Related articles

    9.

    CT screening for lung cancer: five-year prospective experience.

    Swensen SJ, Jett JR, Hartman TE, Midthun DE, Mandrekar SJ, Hillman SL, Sykes AM, Aughenbaugh GL, Bungum AO, Allen KL.

    Radiology. 2005 Apr;235(1):259-65. Epub 2005 Feb 4.PMID: 15695622 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.

    Schild SE, Bonner JA, Shanahan TG, Brooks BJ, Marks RS, Geyer SM, Hillman SL, Farr GH Jr, Tazelaar HD, Krook JE, Geoffroy FJ, Salim M, Arusell RM, Mailliard JA, Schaefer PL, Jett JR.

    Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):943-51.PMID: 15234027 [PubMed - indexed for MEDLINE]Related articles

    11.

    A quality-adjusted reanalysis of a Phase III trial comparing once-daily thoracic radiation vs. twice-daily thoracic radiation in patients with limited-stage small-cell lung cancer(1).

    Sloan JA, Bonner JA, Hillman SL, Allmer C, Shanahan TG, Brooks BJ, Marks RS, Vargas-Chanes D, Jett JR.

    Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):371-81.PMID: 11872282 [PubMed - indexed for MEDLINE]Related articles

    12.

    Screening for lung cancer with low-dose spiral computed tomography.

    Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC.

    Am J Respir Crit Care Med. 2002 Feb 15;165(4):508-13.PMID: 11850344 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Behavioral disturbances in geropsychiatric inpatients across dementia types.

    Kunik ME, Huffman JC, Bharani N, Hillman SL, Molinari VA, Orengo CA.

    J Geriatr Psychiatry Neurol. 2000 Spring;13(1):49-52.PMID: 10753008 [PubMed - indexed for MEDLINE]Related articles

    14.

    Functional impairment in COPD patients: the impact of anxiety and depression.

    Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S.

    Psychosomatics. 2000 Nov-Dec;41(6):465-71.PMID: 11110109 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease.

    An Y, Young SP, Hillman SL, Van Hove JL, Chen YT, Millington DS.

    Anal Biochem. 2000 Dec 1;287(1):136-43.PMID: 11078593 [PubMed - indexed for MEDLINE]Related articles

    16.

    Assay for free and total carnitine in human plasma using tandem mass spectrometry.

    Stevens RD, Hillman SL, Worthy S, Sanders D, Millington DS.

    Clin Chem. 2000 May;46(5):727-9. No abstract available. PMID: 10794762 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays.

    Chace DH, Adam BW, Smith SJ, Alexander JR, Hillman SL, Hannon WH.

    Clin Chem. 1999 Aug;45(8 Pt 1):1269-77.PMID: 10430794 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis.

    Matern D, Strauss AW, Hillman SL, Mayatepek E, Millington DS, Trefz FK.

    Pediatr Res. 1999 Jul;46(1):45-9.PMID: 10400133 [PubMed - indexed for MEDLINE]Related articles

    20.

    Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry.

    Chace DH, Hillman SL, Van Hove JL, Naylor EW.

    Clin Chem. 1997 Nov;43(11):2106-13.PMID: 9365395 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry.

    Chace DH, Hillman SL, Millington DS, Kahler SG, Adam BW, Levy HL.

    Clin Chem. 1996 Mar;42(3):349-55.PMID: 8598094 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry.

    Chace DH, Hillman SL, Millington DS, Kahler SG, Roe CR, Naylor EW.

    Clin Chem. 1995 Jan;41(1):62-8.PMID: 7813082 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...